ArticleMolecular cancer therapeutics2013

NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.

Roshan J Thapa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.